Triasima Portfolio Management Inc. Edwards Lifesciences Corp Transaction History

Triasima Portfolio Management Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$86.5 - $128.27 $310,535 - $460,489	-3,590 Reduced 95.1%	185 $17,000
Q1 2022 Mar 10, 2023	BUY	$101.96 - $128.34 $384,899 - $484,483	3,775 New	3,775 $444,000
Q1 2022 Jul 20, 2022	BUY	$101.96 - $128.34 $15,293 - $19,251	150 Added 4.14%	3,775 $444,000
Q4 2021 Mar 10, 2023	BUY	$106.37 - $130.68 $14,891 - $18,295	140 Added 4.02%	3,625 $470,000
Q4 2021 Jul 20, 2022	BUY	$106.37 - $130.68 $14,891 - $18,295	140 Added 4.02%	3,625 $471,000
Q3 2021 Mar 10, 2023	BUY	$102.91 - $122.75 $19,038 - $22,708	185 Added 5.61%	3,485 $395,000
Q3 2021 Jul 20, 2022	BUY	$102.91 - $122.75 $19,038 - $22,708	185 Added 5.61%	3,485 $393,000
Q2 2021 Mar 10, 2023	BUY	$83.84 - $104.76 $8,384 - $10,476	100 Added 3.13%	3,300 $342,000
Q2 2021 Jul 20, 2022	BUY	$83.84 - $104.76 $8,384 - $10,476	100 Added 3.13%	3,300 $341,000
Q4 2020 Mar 10, 2023	BUY	$71.69 - $91.23 $229,408 - $291,936	3,200 New	3,200 $292,000
Q4 2020 Jul 20, 2022	BUY	$71.69 - $91.23 $229,408 - $291,936	3,200 New	3,200 $292,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Triasima Portfolio Management Inc., based on Form 13F filings with the SEC.

Stay updated on Triasima Portfolio Management Inc. with notifications on news.